In vitro Activity of Aryl Fluoroquinolones, Abbott 56619 and Abbott 56620, Compared to Ciprofloxacin, Norfloxacin and Beta-Lactams versus Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
- 1 January 1986
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 32 (5) , 425-430
- https://doi.org/10.1159/000238446
Abstract
The new aryl fluoroquinolones, Abbott 56619 and Abbott 56620, were compared to ciprofloxacin, norfloxacin and newer β-lactam agents in standardized microliter testing versus multidrug-resistant gram-negative bacilli. Ciprofloxacin, followed by Abbott 56620, was generally the most active quinolone and imipenem the most active β-lactam agent.Keywords
This publication has 0 references indexed in Scilit: